171.31
BATS BZX Real-Time Price
As of 2:22pm ET
 -1.87 / -1.08%
Today’s Change
142.81
Today|||52-Week Range
256.80
+4.73%
Year-to-Date
Allergan (AGN) Presents Positive Data on Glaucoma Candidate
Jun 14 / Zacks.com - Paid Partner Content
Amgen's (AMGN) Prolia Gets Label Expansion Approval in Europe
Jun 11 / Zacks.com - Paid Partner Content
Analysts Remain Bullish on Flexion Therapeutics
Jun 12 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: MRK Impresses at ASCO, LLY Gets FDA Nod for Olumiant
Jun 08 / Zacks.com - Paid Partner Content
Allergan's Second Anti-CGRP Drug Positive in Mid-Stage Study
Jun 12 / Zacks.com - Paid Partner Content
Allergan Requests Shareholders to Veto Management Change
Jun 06 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close173.18
Today’s open170.94
Day’s range170.60 - 172.36
Volume48,092
Average volume (3 months)3,150,280
Market cap$52.3B
Data as of 2:22pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)-134.55%
Earnings growth (this year)-2.09%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+9.40%
P/E ratioNM
Price/Sales3.43
Price/Book0.74

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.33-0.92%
LLYEli Lilly and Co-1.11-1.28%
ABTAbbott Laboratories-0.20-0.32%
NVONovo Nordisk-0.15-0.33%
Data as of 2:22pm ET, 06/18/2018

Financials

Next reporting dateAugust 22, 2018
EPS forecast (this quarter)$4.08
Annual revenue (last year)$15.9B
Annual profit (last year)-$4.1B
Net profit margin-23.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Executive Vice President-
Global Operations
Wayne R. Swanton
Corporate headquarters
Dublin, Dublin

Forecasts